Prescient Healthcare Group Strengthens Offerings with Uptake Acquisition

Prescient Healthcare Group Acquires Uptake

On January 9, 2026, Prescient Healthcare Group announced the exciting acquisition of Uptake Strategies Ltd., a prominent healthcare consultancy known for its exceptional services in the pharmaceutical and biotech sectors. This strategic union aims to merge complementary expertise and shared values, ultimately improving outcomes for clients and the patients they serve.

A New Era of Collaboration

This acquisition signals a new chapter for both organizations, where they aim to enhance their capabilities and client delivery in the healthcare market. Prescient operates on a global scale with offices in the US, UK, India, Spain, and Germany. Its focus spans across three key practices—Medical, Competitive Strategy, and Commercial Practice. With the acquisition, the latter will be co-led by Prescient's Simon Campling and Uptake's Managing Director, Maxine Smith.

Stephanie Hall, the CEO and Founder of Uptake, is excited to join Prescient’s Board while taking on the role of Global Practice Lead for Commercial. She emphasizes the shared commitment between the two companies, making it an ideal partnership to pursue new growth opportunities while preserving the values that have defined Uptake for two decades.

Jason McKenna, Prescient's CEO, expressed enthusiasm for the partnership, stating, “Uptake's reputation for excellence, innovation, and cultural integrity aligns perfectly with our own ambitions.” He highlighted that this collaboration would significantly enhance Prescient's ability to provide integrated commercial, medical, and strategic solutions globally, ultimately benefiting patients through better-informed decisions.

Bridging Strengths and Capabilities

The merger of Prescient and Uptake is poised to unlock many synergies and increased capabilities. This acquisition has been supported by Prescient's investment partner, Bridgepoint, which has helped guide the company’s growth and development since 2021. Alan Payne, a partner at Bridgepoint, praised the strategic fit and expertise Uptake brings to the table, stating, “This transaction reflects a disciplined approach to scaling its platform.”

Both firms have established cultures centered around strong values. Prescient, certified as a B-Corp, underscores its commitment to purpose and sustainability, ensuring that the integration process is aligned with these principles. Both teams have already begun planning for a seamless integration to maintain a high level of service for existing clients during this transition.

While the initial focus will be on maintaining the Uptake brand, future branding strategies will involve further evolution once the integration progresses. The goal is to harness the strengths of both organizations for transformative solutions tailored to the pharma and biotech industries, driving better outcomes for patients across the globe.

Conclusion

The acquisition of Uptake by Prescient Healthcare Group exemplifies a strategic partnership built on shared values and goals. Together, they will leverage their combined expertise and global reach to innovate and deliver strategic consulting services that significantly improve patient outcomes. By uniting their strengths, both organizations are well-positioned to navigate the complex landscape of the pharmaceutical industry.

For more information about Prescient Healthcare Group, please visit Prescient’s Website. To learn more about Uptake Strategies, head to Uptake’s Website.